Brewin Dolphin LTD Vaxart, Inc. Transaction History

Brewin Dolphin LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Nov 09, 2023	SELL	$5.64 - $23.33 $4,088 - $16,914	-725 Reduced 5.89%	11,575 $70 Million
Q4 2020 Nov 09, 2023	BUY	$3.5 - $7.98 $21,000 - $47,880	6,000 Added 95.24%	12,300 $70.2 Million
Q3 2020 Nov 09, 2023	SELL	$4.78 - $16.97 $30,950 - $109,880	-6,475 Reduced 50.68%	6,300 $41.9 Million
Q2 2020 Nov 09, 2023	BUY	$1.68 - $8.85 $10,878 - $57,303	6,475 Added 102.78%	12,775 $113 Million
Q1 2020 Nov 09, 2023	BUY	$0.34 - $2.87 $1,903 - $16,069	5,599 Added 798.72%	6,300 $11.2 Million
Q1 2018 Nov 09, 2023	BUY	$4.95 - $9.02 $3,469 - $6,323	701 New	701 $3.73 Million

108

37.9M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.